EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Carvedilol suppresses ryanodine receptor-dependent Ca2+ bursts in human neurons bearing PSEN1 variants found in early onset Alzheimer’s disease

Atsushi Hori, Haruka Inaba, Takashi Hato, Kimie Tanaka, Shoichi Sato, Mizuho Okamoto, Yuna Horiuchi, Faith Jessica Paran iD, Yoko Tabe, Shusuke Mori, Corina Rosales, Wado Akamatsu und 5 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0291887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Atsushi Hori und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Technology, Faculty of Medical Science, Juntendo University, Chiba, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease, Calcium, Calcium Signaling, Neurons. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Seizures are increasingly being recognized as the hallmark of Alzheimer’s disease (AD). Neuronal hyperactivity can be a consequence of neuronal damage caused by abnormal amyloid β (Aß) depositions. However, it can also be a cell-autonomous phenomenon causing AD by Aß-independent mechanisms. Various studies using animal models have shown that Ca 2+ is released from the endoplasmic reticulum (ER) via type 1 inositol triphosphate receptors (InsP 3 R1s) and ryanodine receptors (RyRs). To investigate which is the main pathophysiological mechanism in human neurons, we measured Ca 2+ signaling in neural cells derived from three early-onset AD patients harboring Presenilin-1 variants ( PSEN1 p.A246E, p.L286V, and p.M146L). Of these, it has been reported that PSEN1 p.A246E and p.L286V did not produce a significant amount of abnormal Aß. We found all PSEN1 -mutant neurons, but not wild-type, caused abnormal Ca 2+ -bursts in a manner dependent on the calcium channel, Ryanodine Receptor 2 (RyR2). Indeed, carvedilol, an RyR2 inhibitor, and VK-II-86, an analog of carvedilol without the β-blocking effects, sufficiently eliminated the abnormal Ca 2+ bursts. In contrast, Dantrolene, an inhibitor of RyR1 and RyR3, and Xestospongin c, an IP 3 R inhibitor, did not attenuate the Ca 2+ -bursts. The Western blotting showed that RyR2 expression was not affected by PSEN1 p.A246E, suggesting that the variant may activate the RyR2. The RNA-Seq data revealed that ER-stress responsive genes were increased, and mitochondrial Ca 2+ -transporter genes were decreased in PSEN1 A246E cells compared to the WT neurons. Thus, we propose that aberrant Ca 2+ signaling is a key link between human pathogenic PSEN1 variants and cell-intrinsic hyperactivity prior to deposition of abnormal Aß, offering prospects for the development of targeted prevention strategies for at-risk individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCalciumCalcium SignalingNeuronsPresenilin-1Ryanodine Receptor Calcium Release ChannelCarvedilolFemaleHumansMaleEndoplasmic Reticulum

Substanzen

CalciumPresenilin-1PSEN1 protein, humanRyanodine Receptor Calcium Release ChannelCarvedilol

Autor:innen und Institutionen

  • Department of Clinical Laboratory Technology, Faculty of Medical Science, Juntendo University, Chiba, Japan.
  • Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Division of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
  • Department of Clinical Engineering, Faculty of Medical Science, Juntendo University, Chiba, Japan.
  • Center for Genomic and Regenerative Medicine, School of Medicine, Juntendo University, Tokyo, Japan.
  • Department of Acute Care and Disaster Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

ORCID-Profile: Faith Jessica Paran, Takashi Murayama, Tomohiko Ai, Takashi Miida

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Hori, A., Inaba, H., Hato, T., Tanaka, K., Sato, S., Okamoto, M., Horiuchi, Y., Paran, F. J., Tabe, Y., Mori, S., Rosales, C., Akamatsu, W., Murayama, T., Kurebayashi, N., Sakurai, T., Ai, T., & Miida, T. (2024). Carvedilol suppresses ryanodine receptor-dependent Ca2+ bursts in human neurons bearing PSEN1 variants found in early onset Alzheimer’s disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0291887

Vancouver

Hori A, Inaba H, Hato T, Tanaka K, Sato S, Okamoto M, et al. Carvedilol suppresses ryanodine receptor-dependent Ca2+ bursts in human neurons bearing PSEN1 variants found in early onset Alzheimer’s disease. PLOS ONE. 2024. doi:10.1371/journal.pone.0291887

BibTeX
@article{Hori2024,
  author = {Hori, Atsushi and Inaba, Haruka and Hato, Takashi and Tanaka, Kimie and Sato, Shoichi and Okamoto, Mizuho and Horiuchi, Yuna and Paran, Faith Jessica and Tabe, Yoko and Mori, Shusuke and Rosales, Corina and Akamatsu, Wado and Murayama, Takashi and Kurebayashi, Nagomi and Sakurai, Takashi and Ai, Tomohiko and Miida, Takashi},
  title = {Carvedilol suppresses ryanodine receptor-dependent Ca2+ bursts in human neurons bearing PSEN1 variants found in early onset Alzheimer’s disease},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0291887}
}
Kostenlos starten →